| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 35 | 2022 | 1536 | 3.730 |
Why?
|
| Health Services Accessibility | 15 | 2020 | 581 | 2.320 |
Why?
|
| Early Detection of Cancer | 14 | 2020 | 454 | 2.020 |
Why?
|
| Rural Population | 9 | 2021 | 398 | 1.870 |
Why?
|
| Colorectal Neoplasms | 8 | 2021 | 561 | 1.490 |
Why?
|
| Exercise | 10 | 2022 | 658 | 1.400 |
Why?
|
| Health Status Disparities | 9 | 2020 | 326 | 1.300 |
Why?
|
| Urban Population | 6 | 2021 | 255 | 1.270 |
Why?
|
| Uterine Cervical Neoplasms | 6 | 2020 | 300 | 1.270 |
Why?
|
| South Carolina | 32 | 2021 | 2752 | 1.230 |
Why?
|
| Community-Based Participatory Research | 8 | 2018 | 133 | 1.210 |
Why?
|
| Safety-net Providers | 3 | 2017 | 20 | 1.160 |
Why?
|
| Neoplasms | 13 | 2020 | 1667 | 1.080 |
Why?
|
| Nursing Staff, Hospital | 3 | 2021 | 62 | 1.050 |
Why?
|
| Mass Screening | 5 | 2020 | 843 | 1.030 |
Why?
|
| Mammography | 6 | 2020 | 310 | 0.980 |
Why?
|
| Personnel Turnover | 2 | 2021 | 14 | 0.960 |
Why?
|
| Nurse Administrators | 2 | 2021 | 16 | 0.950 |
Why?
|
| Medication Adherence | 4 | 2021 | 335 | 0.950 |
Why?
|
| Job Satisfaction | 2 | 2021 | 62 | 0.930 |
Why?
|
| Female | 70 | 2022 | 38074 | 0.920 |
Why?
|
| Cancer Survivors | 3 | 2020 | 146 | 0.870 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2020 | 99 | 0.840 |
Why?
|
| Healthcare Disparities | 10 | 2022 | 378 | 0.800 |
Why?
|
| Humans | 90 | 2022 | 68618 | 0.800 |
Why?
|
| Socioeconomic Factors | 13 | 2021 | 955 | 0.770 |
Why?
|
| Intention | 2 | 2021 | 80 | 0.770 |
Why?
|
| Middle Aged | 46 | 2021 | 21147 | 0.760 |
Why?
|
| Community Networks | 7 | 2014 | 96 | 0.730 |
Why?
|
| Health Promotion | 4 | 2019 | 407 | 0.720 |
Why?
|
| Patient Selection | 5 | 2018 | 592 | 0.700 |
Why?
|
| Health Care Costs | 2 | 2021 | 346 | 0.660 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 172 | 0.650 |
Why?
|
| Health Behavior | 5 | 2018 | 458 | 0.650 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 96 | 0.650 |
Why?
|
| Incidence | 14 | 2021 | 1603 | 0.640 |
Why?
|
| Adult | 43 | 2021 | 21403 | 0.640 |
Why?
|
| United States | 21 | 2022 | 7367 | 0.620 |
Why?
|
| Medically Uninsured | 1 | 2018 | 99 | 0.610 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 180 | 0.580 |
Why?
|
| Terminal Care | 1 | 2018 | 92 | 0.570 |
Why?
|
| Mobile Applications | 1 | 2018 | 138 | 0.550 |
Why?
|
| Wounds and Injuries | 2 | 2019 | 334 | 0.520 |
Why?
|
| Censuses | 1 | 2015 | 6 | 0.500 |
Why?
|
| Lung Neoplasms | 7 | 2022 | 1173 | 0.500 |
Why?
|
| Preventive Health Services | 1 | 2015 | 86 | 0.490 |
Why?
|
| Male | 37 | 2022 | 37321 | 0.450 |
Why?
|
| Diet | 4 | 2021 | 514 | 0.440 |
Why?
|
| Aged | 23 | 2021 | 14862 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2020 | 767 | 0.420 |
Why?
|
| Medically Underserved Area | 3 | 2020 | 85 | 0.420 |
Why?
|
| Body Mass Index | 9 | 2017 | 867 | 0.410 |
Why?
|
| Registries | 9 | 2022 | 733 | 0.410 |
Why?
|
| Preventive Medicine | 3 | 2006 | 48 | 0.400 |
Why?
|
| Risk Assessment | 2 | 2015 | 2007 | 0.390 |
Why?
|
| Prostatic Neoplasms | 5 | 2022 | 778 | 0.380 |
Why?
|
| Retrospective Studies | 11 | 2022 | 7277 | 0.360 |
Why?
|
| Geographic Mapping | 3 | 2020 | 19 | 0.360 |
Why?
|
| Quality of Life | 4 | 2022 | 1515 | 0.360 |
Why?
|
| Social Stigma | 2 | 2022 | 53 | 0.360 |
Why?
|
| Telemedicine | 1 | 2018 | 700 | 0.360 |
Why?
|
| Health Literacy | 2 | 2021 | 63 | 0.350 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 792 | 0.350 |
Why?
|
| Cohort Studies | 9 | 2020 | 2358 | 0.330 |
Why?
|
| Receptors, Progesterone | 2 | 2022 | 57 | 0.320 |
Why?
|
| Receptors, Estrogen | 2 | 2022 | 142 | 0.310 |
Why?
|
| Medicaid | 4 | 2021 | 302 | 0.300 |
Why?
|
| Residence Characteristics | 4 | 2021 | 252 | 0.300 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 117 | 0.300 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 4848 | 0.300 |
Why?
|
| Feeding Behavior | 3 | 2021 | 224 | 0.290 |
Why?
|
| Motor Activity | 3 | 2015 | 621 | 0.280 |
Why?
|
| Contraceptives, Oral | 2 | 2016 | 28 | 0.280 |
Why?
|
| Obesity | 3 | 2015 | 1076 | 0.270 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2016 | 931 | 0.260 |
Why?
|
| Endometrial Neoplasms | 2 | 2016 | 69 | 0.260 |
Why?
|
| Social Conformity | 1 | 2005 | 2 | 0.250 |
Why?
|
| Social Desirability | 1 | 2005 | 9 | 0.250 |
Why?
|
| Self Disclosure | 1 | 2005 | 55 | 0.250 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 2800 | 0.250 |
Why?
|
| Health Education | 2 | 2019 | 279 | 0.240 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 468 | 0.240 |
Why?
|
| Energy Metabolism | 1 | 2005 | 222 | 0.220 |
Why?
|
| Young Adult | 10 | 2020 | 5717 | 0.210 |
Why?
|
| Neoplasm Staging | 5 | 2021 | 800 | 0.200 |
Why?
|
| Food Preferences | 1 | 2021 | 46 | 0.190 |
Why?
|
| Research Design | 2 | 2016 | 729 | 0.190 |
Why?
|
| Health Communication | 2 | 2018 | 19 | 0.190 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 63 | 0.190 |
Why?
|
| Public Health | 2 | 2020 | 201 | 0.190 |
Why?
|
| Population Surveillance | 2 | 2020 | 285 | 0.190 |
Why?
|
| Cost of Illness | 2 | 2022 | 206 | 0.180 |
Why?
|
| Workplace | 1 | 2020 | 75 | 0.180 |
Why?
|
| Vulnerable Populations | 3 | 2016 | 84 | 0.180 |
Why?
|
| Vegans | 1 | 2019 | 2 | 0.180 |
Why?
|
| Adaptation, Psychological | 3 | 2019 | 447 | 0.170 |
Why?
|
| Prognosis | 5 | 2021 | 2093 | 0.170 |
Why?
|
| Resource Allocation | 1 | 2020 | 35 | 0.170 |
Why?
|
| Geographic Information Systems | 1 | 2020 | 34 | 0.170 |
Why?
|
| Restaurants | 1 | 2019 | 29 | 0.170 |
Why?
|
| Respiratory System | 2 | 2010 | 28 | 0.170 |
Why?
|
| Survivors | 1 | 2022 | 256 | 0.170 |
Why?
|
| Motivation | 2 | 2021 | 561 | 0.170 |
Why?
|
| Papillomavirus Vaccines | 1 | 2020 | 93 | 0.170 |
Why?
|
| Drama | 1 | 2019 | 6 | 0.170 |
Why?
|
| Specialization | 1 | 2019 | 66 | 0.170 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 19 | 0.170 |
Why?
|
| Religion and Medicine | 1 | 2019 | 25 | 0.170 |
Why?
|
| Incidental Findings | 1 | 2019 | 42 | 0.160 |
Why?
|
| Financing, Government | 1 | 2018 | 16 | 0.160 |
Why?
|
| Health Surveys | 4 | 2022 | 489 | 0.160 |
Why?
|
| Cardiovascular System | 2 | 2010 | 85 | 0.160 |
Why?
|
| False Positive Reactions | 1 | 2019 | 95 | 0.160 |
Why?
|
| Physical Fitness | 2 | 2010 | 117 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 331 | 0.160 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 43 | 0.160 |
Why?
|
| Information Dissemination | 1 | 2019 | 113 | 0.160 |
Why?
|
| Social Marketing | 2 | 2010 | 33 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 194 | 0.150 |
Why?
|
| Critical Care | 1 | 2020 | 263 | 0.150 |
Why?
|
| Statistics as Topic | 1 | 2018 | 219 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 438 | 0.150 |
Why?
|
| Community Health Centers | 1 | 2017 | 26 | 0.150 |
Why?
|
| Faith Healing | 1 | 2017 | 3 | 0.150 |
Why?
|
| Health Policy | 1 | 2019 | 221 | 0.150 |
Why?
|
| Community-Institutional Relations | 1 | 2017 | 59 | 0.150 |
Why?
|
| Perception | 1 | 2018 | 189 | 0.150 |
Why?
|
| Emotions | 1 | 2019 | 244 | 0.140 |
Why?
|
| Life Style | 2 | 2013 | 338 | 0.140 |
Why?
|
| Body Weight | 2 | 2013 | 554 | 0.140 |
Why?
|
| Evidence-Based Practice | 2 | 2017 | 146 | 0.140 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2016 | 8 | 0.140 |
Why?
|
| Health Personnel | 1 | 2019 | 286 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2017 | 86 | 0.140 |
Why?
|
| Survival Analysis | 5 | 2019 | 714 | 0.140 |
Why?
|
| Schools, Medical | 1 | 2017 | 157 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2017 | 79 | 0.140 |
Why?
|
| Nutritional Sciences | 1 | 2016 | 21 | 0.140 |
Why?
|
| Quality of Health Care | 2 | 2016 | 322 | 0.130 |
Why?
|
| Progestins | 1 | 2015 | 19 | 0.130 |
Why?
|
| Self Care | 1 | 2018 | 253 | 0.130 |
Why?
|
| Overweight | 2 | 2014 | 186 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 319 | 0.130 |
Why?
|
| Women's Health | 1 | 2016 | 148 | 0.130 |
Why?
|
| Religion | 1 | 2015 | 23 | 0.130 |
Why?
|
| Focus Groups | 3 | 2021 | 247 | 0.130 |
Why?
|
| Health Status | 2 | 2019 | 429 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 1085 | 0.120 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 235 | 0.120 |
Why?
|
| Accelerometry | 1 | 2015 | 61 | 0.120 |
Why?
|
| Telecommunications | 2 | 2012 | 31 | 0.120 |
Why?
|
| Self-Help Groups | 2 | 2012 | 38 | 0.120 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 546 | 0.120 |
Why?
|
| Religion and Psychology | 1 | 2014 | 15 | 0.120 |
Why?
|
| Survival Rate | 3 | 2016 | 1056 | 0.120 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 102 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2018 | 1330 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 81 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 1553 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 244 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2015 | 330 | 0.110 |
Why?
|
| Forecasting | 1 | 2015 | 277 | 0.110 |
Why?
|
| Smoking | 2 | 2019 | 1452 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 442 | 0.110 |
Why?
|
| Depression | 2 | 2022 | 943 | 0.110 |
Why?
|
| Homosexuality, Male | 1 | 2013 | 34 | 0.110 |
Why?
|
| Communication | 2 | 2020 | 329 | 0.110 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2013 | 53 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 694 | 0.100 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 123 | 0.100 |
Why?
|
| Body Image | 1 | 2013 | 100 | 0.100 |
Why?
|
| Risk Factors | 7 | 2019 | 5731 | 0.100 |
Why?
|
| Anxiety | 1 | 2015 | 422 | 0.100 |
Why?
|
| Patient Compliance | 2 | 2016 | 402 | 0.100 |
Why?
|
| Models, Psychological | 2 | 2010 | 180 | 0.100 |
Why?
|
| Risk | 3 | 2018 | 563 | 0.100 |
Why?
|
| Universities | 1 | 2012 | 191 | 0.090 |
Why?
|
| Geography | 3 | 2019 | 80 | 0.090 |
Why?
|
| Digestive System Neoplasms | 1 | 2010 | 13 | 0.090 |
Why?
|
| Travel | 2 | 2020 | 38 | 0.090 |
Why?
|
| Women | 1 | 2010 | 40 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7029 | 0.090 |
Why?
|
| Biomarkers | 1 | 2015 | 1593 | 0.090 |
Why?
|
| Hypertension | 1 | 2018 | 1535 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 378 | 0.080 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 40 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1070 | 0.080 |
Why?
|
| Community Participation | 1 | 2009 | 42 | 0.080 |
Why?
|
| Demography | 1 | 2009 | 279 | 0.080 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2009 | 40 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 940 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2020 | 468 | 0.080 |
Why?
|
| Language | 1 | 2009 | 120 | 0.080 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2020 | 73 | 0.080 |
Why?
|
| Social Support | 1 | 2011 | 423 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 191 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 445 | 0.070 |
Why?
|
| Adolescent | 5 | 2019 | 8912 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 3259 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2012 | 703 | 0.070 |
Why?
|
| Southeastern United States | 2 | 2018 | 281 | 0.070 |
Why?
|
| China | 1 | 2006 | 138 | 0.070 |
Why?
|
| Postmenopause | 1 | 2006 | 93 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2009 | 310 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 2006 | 150 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 536 | 0.060 |
Why?
|
| HIV Infections | 1 | 2013 | 791 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2077 | 0.060 |
Why?
|
| Personality Assessment | 1 | 2005 | 71 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2324 | 0.060 |
Why?
|
| Bias | 1 | 2005 | 148 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2015 | 3705 | 0.060 |
Why?
|
| Recreation | 1 | 2003 | 19 | 0.060 |
Why?
|
| Minority Groups | 2 | 2017 | 197 | 0.060 |
Why?
|
| Time Factors | 3 | 2019 | 4655 | 0.050 |
Why?
|
| Louisiana | 1 | 2022 | 37 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2015 | 880 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2279 | 0.050 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 47 | 0.050 |
Why?
|
| North Carolina | 1 | 2022 | 224 | 0.050 |
Why?
|
| Teaching Materials | 1 | 2021 | 16 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2021 | 191 | 0.050 |
Why?
|
| Comprehension | 1 | 2021 | 71 | 0.050 |
Why?
|
| Health Facilities | 1 | 2020 | 36 | 0.050 |
Why?
|
| Professional Practice Location | 1 | 2019 | 19 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2014 | 1342 | 0.040 |
Why?
|
| Fast Foods | 1 | 2019 | 8 | 0.040 |
Why?
|
| Educational Status | 1 | 2020 | 273 | 0.040 |
Why?
|
| Food | 1 | 2019 | 52 | 0.040 |
Why?
|
| Vaccination | 1 | 2020 | 189 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2019 | 80 | 0.040 |
Why?
|
| Child | 2 | 2020 | 6405 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 130 | 0.040 |
Why?
|
| Learning | 1 | 2021 | 186 | 0.040 |
Why?
|
| Publication Bias | 1 | 2018 | 8 | 0.040 |
Why?
|
| Clinical Studies as Topic | 1 | 2018 | 7 | 0.040 |
Why?
|
| Culture | 1 | 2019 | 75 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 1046 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 241 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2019 | 156 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 390 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 1054 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2017 | 24 | 0.040 |
Why?
|
| Health Priorities | 1 | 2017 | 23 | 0.040 |
Why?
|
| Environment | 1 | 2018 | 115 | 0.040 |
Why?
|
| Radiography | 1 | 2019 | 572 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1851 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2019 | 369 | 0.040 |
Why?
|
| Nurse-Patient Relations | 1 | 2016 | 34 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2017 | 101 | 0.030 |
Why?
|
| Prevalence | 2 | 2014 | 1619 | 0.030 |
Why?
|
| Levonorgestrel | 1 | 2015 | 6 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2016 | 127 | 0.030 |
Why?
|
| Contraceptive Agents, Female | 1 | 2015 | 16 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 21 | 0.030 |
Why?
|
| Hospital Records | 1 | 2014 | 3 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 772 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 59 | 0.030 |
Why?
|
| Birth Certificates | 1 | 2014 | 16 | 0.030 |
Why?
|
| Population Density | 1 | 2014 | 18 | 0.030 |
Why?
|
| Government Programs | 1 | 2014 | 16 | 0.030 |
Why?
|
| Capacity Building | 1 | 2014 | 17 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 6 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2014 | 35 | 0.030 |
Why?
|
| Kansas | 1 | 2014 | 1 | 0.030 |
Why?
|
| Food Supply | 1 | 2014 | 43 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2014 | 117 | 0.030 |
Why?
|
| Fruit | 1 | 2014 | 86 | 0.030 |
Why?
|
| Vegetables | 1 | 2014 | 76 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 300 | 0.030 |
Why?
|
| Florida | 1 | 2014 | 221 | 0.030 |
Why?
|
| Coinfection | 1 | 2013 | 30 | 0.030 |
Why?
|
| Decision Making | 1 | 2016 | 410 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 3187 | 0.030 |
Why?
|
| Family Relations | 1 | 2012 | 47 | 0.030 |
Why?
|
| Mentors | 1 | 2012 | 81 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2014 | 419 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 521 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2013 | 210 | 0.020 |
Why?
|
| Researcher-Subject Relations | 1 | 2010 | 4 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 209 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2010 | 46 | 0.020 |
Why?
|
| Models, Nursing | 1 | 2010 | 23 | 0.020 |
Why?
|
| Audiovisual Aids | 1 | 2010 | 20 | 0.020 |
Why?
|
| Texas | 1 | 2010 | 92 | 0.020 |
Why?
|
| Cultural Competency | 1 | 2010 | 42 | 0.020 |
Why?
|
| Trust | 1 | 2010 | 75 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1420 | 0.020 |
Why?
|
| Exercise Test | 1 | 2010 | 242 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 425 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 240 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 2334 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 306 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2010 | 502 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2013 | 824 | 0.020 |
Why?
|
| Regional Medical Programs | 1 | 2006 | 22 | 0.020 |
Why?
|
| Nursing Research | 1 | 2006 | 40 | 0.020 |
Why?
|